FindTrial
Sign In

Effects of pacemaker implantation on sudden cardiac death rate and quality of life in atrial fibrillation patients with ventricular pauses

Effects of pacemaker implantation on sudden cardiac death rate and quality of life in atrial fibrillation patients with ventricular pauses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012396
Enrollment
Unknown
Registered
2017-08-17
Start date
1998-01-18
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

persistent atrial fibrillation with ventricular pauses

Interventions

Pacemaker group/control grounp:Implantable pacemaker

Sponsors

The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) the persistent atrial fibrillation; (2) the dynamic ecg showed awakening condition, merge ventricular atrial fibrillation pause time for 3 seconds or more; (3) the use of anticoagulation and antiplatelet drugs (aspirin: 100 mg/day; warfarin: control INR: 2-3).

Exclusion criteria

Exclusion criteria: (1) lack of ability to care for life or physical, language dysfunction; (2) using the known RR interphase the influence of drugs, including digitalis, calcium channel blockers, beta blockers, class III anti-arrhythmic drugs

Design outcomes

Primary

MeasureTime frame
sudden cardiac death;—

Countries

China

Contacts

Public ContactLi YD

The First Affiliated Hospital, Xinjiang Medical University

289108564@qq.com+86 15311422033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026